Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer’s Disease (R01 – Clinical Trial Not Allowed)

Funder: National Institutes of Health

Due Date: 3/26/2018

Budget: $8,000,000

Opportunity: RFA-AG-18-027


This Funding Opportunity Announcement (FOA) invites innovative research focused on understanding the role of exosome biogenesis and secretion in modulating and propagation of early pathogenesis in sporadic and late-onset Alzheimers disease (AD). Specifically, this FOA encourages collaborative approaches designed to identify and characterize the regulation of molecular machines that are responsible for exosome biogenesis and the secretion of exosomal cargo molecules in AD.

Leave a Reply